InsidersTradesSigma
Follow the 哈三联 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 哈三联 has recorded 4 insider filings. Market capitalisation: €3.8bn. The latest transaction was filed on 7 July 2025 (Sale). Among the most active insiders: 范庆吉. The full history is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€883,181
4 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,097 of 28,775 companies
21.1
score / 100
Value18
Quality24
FCF yld-7.6%
Earn yld-9.0%
EV/EBITDA·
ROE-16%
Gross mgn38%
Net mgn-43%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2025
About 哈三联
哈三联 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It specializes in the research and development of pharmaceutical products.